Internal Server Error

Bluesight - About the company

Bluesight is a series A company based in Alexandria (United States), founded in 2011 by Kevin Macdonald. It operates as an AI-based medication data and analytics platform for pharmacies. Bluesight has raised $10.5M in funding from Thoma Bravo and New Leaf Venture Partners. The company has 3 active competitors, including 1 that is funded. Its top competitors are DocRX and HelioMetrics.

Company Details

AI-based medication data and analytics platform for pharmacies. It offers pharmaceutical intelligence and provides hospital pharmacies solutions for managing drug diversion, RFID medication monitoring, and pharmacy purchasing. They provide cloud-based software that uses data from electronic medical records and automated dispensing cabinets to proactively detect drug diversion. Additionally, they offer a practice guide for drug diversion programs and use analytics to improve drug spending and workflows.
Social
XFacebook
Email ID
*****@kitcheck.com
Phone Number
+1 **********
Registered Address
Washington, District of Columbia
Key Metrics
Founded Year
2011
Location
Alexandria, United States
Stage
Series A
Total Funding
$10.5M in 2 rounds
Latest Funding Round
Investors
Ranked
Employee Count
219 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Bluesight's company profile

Bluesight's funding and investors

Bluesight has raised a total funding of $10.5M over 2 rounds. Its first funding round was on Jul 16, 2013. Its latest funding round was a PE round on Jul 17, 2023 for $*****. 2 investors participated in its latest round. Bluesight has 7 institutional investors.

Here is the list of recent funding rounds of Bluesight:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jul 17, 2023
1841245
PE
9863814
4919091
5676591
8518190
Jul 16, 2013
1687307
Series A
6305284
3839297
lockAccess funding benchmarks and valuations. Sign up today!

Bluesight's founders and board of directors

Founder? Claim Profile
The founders of Bluesight is Kevin Macdonald. Kevin Macdonald is the CEO of Bluesight.
Here are the details of Bluesight's key team members:

Bluesight's Board of Directors

Bluesight's board has 7 active members. Kevin Macdonald, Adam Grossman, Robert Ward, Vijay Lathi, Marcia Radosevich, Timothy Kress-Spatz and Mark Rosenbaum are independent board members.
Here is the list of Bluesight's board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
13y 2m
htzgvdi
Independent board member
-
Current
2y 6m
bquqjui
Independent board member
-
Current
1y 5m
{avubmo
Independent board member
-
Current
8y 3m
hnkpmrw
Independent board member
-
Current
6y 9m
dhvgsju
Independent board member
-
Current
7y 4m
qbyzbo{
Independent board member
-
Current
2y 5m

Bluesight's employee count trend

Bluesight has 219 employees as of Aug 26. Here is Bluesight's employee count trend over the years:
Employee count trend for Bluesight
lockUncover Bluesight's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Bluesight's Competitors and alternates

Top competitors of Bluesight include DocRX and HelioMetrics. Here is the list of Top 10 competitors of Bluesight, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Bluesight
Bluesight
2011, Alexandria (United States), Series A
AI-based medication data and analytics platform for pharmacies
$10.5M
57/100
2nd
Logo for DocRX
DocRX
2008, Mobile (United States), Unfunded
Healthcare solutions provider specializing in physician dispensing and compliance
-
-
29/100
3rd
Logo for HelioMetrics
HelioMetrics
2013, Minneapolis (United States), Unfunded
Healthcare analytics software for Rx drug diversion and patient privacy
-
-
22/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Bluesight's competitors? Click here to see the top ones

Bluesight's Investments and acquisitions

Bluesight has acquired 3 companies including Protenus, Sectyr and Medacist. Bluesight has not made any investments as of now.
Here is the list of its acquisitions:
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Jan 09, 2025
Acquisition
2014
Baltimore (United States)
Oct 18, 2024
Acquisition
2017
Scottsdale (United States)
Jul 17, 2023
Acquisition
1998
Cheshire (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all acquisitions by Bluesight

Reports related to Bluesight

Here is the latest report on Bluesight's sector:

News related to Bluesight

lockFilter this list
Media has covered Bluesight for a total of 4 events in the last 1 year, 2 of them have been about company updates and 2 about partnerships.
•
Bluesight’s Acquisition of ProtenusGlobal Legal Chronicle•Jan 23, 2025•Bluesight, Protenus, Kirkland & Ellis, DLA Piper and 1 other
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Bluesight

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford